Development
Taysha Gene Therapies, Inc.
TSHA
$2.84
-$0.04-1.39%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 378.86% | -31.94% | -34.36% | -41.06% | -81.83% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -28.32% | 7.60% | 0.20% | -34.81% | 39.99% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -7.70% | -23.98% | -18.27% | -9.27% | -5.67% |
| Total Current Assets | 299.53% | -29.57% | -32.31% | -39.59% | -78.19% |
|
|
|||||
| Total Current Assets | 299.53% | -29.57% | -32.31% | -39.59% | -78.19% |
| Net Property, Plant & Equipment | -67.13% | -59.86% | -54.12% | -48.81% | 57.70% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -34.82% | -34.44% | -0.30% | 5.58% | 35.94% |
| Total Assets | 75.63% | -42.71% | -38.79% | -40.98% | -53.76% |
|
|
|||||
| Total Accounts Payable | -50.69% | -55.08% | -59.08% | -49.70% | -30.84% |
| Total Accrued Expenses | -22.38% | 6.30% | -40.31% | -45.70% | -16.79% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 4,846.49% | 674.50% | 860.58% | 777.58% | -8.95% |
| Total Other Current Liabilities | 4,846.49% | 674.50% | 860.58% | 777.58% | -8.95% |
| Total Current Liabilities | 444.53% | 17.90% | 12.01% | 21.34% | -23.31% |
|
|
|||||
| Total Current Liabilities | 444.53% | 17.90% | 12.01% | 21.34% | -23.31% |
| Long-Term Debt | 2.05% | 2.06% | 2.07% | 2.08% | 35.82% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -21.81% | -20.14% | -18.70% | -21.08% | -4.18% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 51.22% | 164.66% | -14.33% | 10.58% | 30.48% |
| Total Liabilities | 144.05% | 8.24% | 1.13% | 5.70% | -0.30% |
|
|
|||||
| Common Stock & APIC | 43.29% | 15.38% | 20.10% | 21.56% | 9.64% |
| Retained Earnings | -62.09% | -38.80% | -46.65% | -70.36% | -86.73% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -541.43% | -213.46% | -129.47% | -99.01% | -92.08% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -541.43% | -213.46% | -129.47% | -99.01% | -92.08% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -541.43% | -213.46% | -129.47% | -99.01% | -92.08% |
|
|
|||||